Figure 1 from Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study

<p>Patient disposition.</p>

Saved in:

Bibliografiske detaljer
Hovedforfatter:	Kohei Shitara (15043443) (author)
Andre forfattere:	Motohiro Tamiya (17866315) (author), Kyoichi Okishio (17866312) (author), Hisashi Hosaka (22420197) (author), Katsunori Shinozaki (22420200) (author), Nobuhiko Seki (22420203) (author), Hiroki Hara (15026339) (author), Yukiya Narita (22420206) (author), Takeshi Shiraishi (22420209) (author), Yosuke Tamura (22420212) (author), Akihito Tsuji (21430589) (author), Kunihiro Tsuji (22420215) (author), Naohiro Watanabe (22420218) (author), Hiroshi Tanaka (15014300) (author), Toshifumi Yamaguchi (22420221) (author), Kensei Yamaguchi (15054104) (author), Hiroki Izumi (15047559) (author), Yasunori Ushida (22420224) (author), Hideaki Suna (22420227) (author)
Udgivet:	2025
Fag:	Cancer Immuno-oncology Clinical Research and Trials Biomarkers For Immunotherapy Clinical Trial Results Phase II clinical trials Checkpoint Blockade Gastrointestinal Cancers Stomach cancer Lung Cancer
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Lignende værker